When subjects violate the research covenant: Lessons learned from a failed clinical trial of fecal microbiota transplantation

American Journal of Gastroenterology

Volumn 111, Issue 11, 2016, Pages 1508-1510

  Kahn, Stacy A ^a,b   Rubin, David T ^a,b  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL (TOPIC); COLONOSCOPY; FECAL MICROBIOTA TRANSPLANTATION; HUMAN; INFLAMMATORY BOWEL DISEASE; MEDICAL RESEARCH; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; ULCERATIVE COLITIS; DECEPTION; PATIENT DROPOUT; RESEARCH ETHICS; RESEARCH SUBJECT;

CLINICAL TRIALS AS TOPIC; COLITIS, ULCERATIVE; COLONOSCOPY; DECEPTION; ETHICS, RESEARCH; FECAL MICROBIOTA TRANSPLANTATION; HUMANS; PATIENT DROPOUTS; RESEARCH SUBJECTS;

EID: 84966558977     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2016.153     Document Type: Article

References (22)

1. Nuremberg Code. In: Trials of War Criminals Before the Nuremberg Military Tribunals Under Control Council Law. No. 10, Vol. Washington, DC, USA: U.S. Government Printing Office; 1949:181-182.
2. National Commission for the Proptection of Human Subjects of Biomedical and Behavioral Research. The Belmont report: Ethical principles and guidelines for the protection of human subjects of research, Bethesda, MD, USA: National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research; 1978:30. (Distributed by ERIC Clearinghouse: Washington, DC, USA.)
3. Code of Federal Regulations, Title 45, Part 46. US Department of Health and Human Services; 2009; http://www.hhs.gov/ohrp/regulations-andpolicy/ regulations/45-cfr-46/index.html. Accessed March 15, 2016.
4. Guidance for Industry E6 Good Clinical Practice: Consolidated Guidance, 1996, International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonized Tripartite Guideline. Guideline for Good Clinical Practice E6(R1). 1996; http://www.ich.org/fileadmin/Public-Web-Site/ICH-Products/ Guidelines/Efficacy/E6/E6-R1-Guideline.pdf; accessed March 15, 2016.
5. Resnik DB, Ness E. Participants' responsibilities in clinical research. J Med Ethics 2012; 38: 746-50.
6. Dresser R. Subversive subjects: rule-breaking and deception in clinical trials. J Law Med Ethics 2013; 41: 829-40.
7. Resnik DB, McCann DJ. Deception by research participants. N Engl J Med 2015; 373: 1192-3.
8. Ho N, Prasad V. Lacking the incentive to cure? Recurring Clostridium difficile diarrhea and our reluctance to use fecal transplantation. J Clin Gastroenterol 2011; 45: 379-80.
9. El-Matary W, Simpson R, Ricketts-Burns N. Fecal microbiota transplantation: are we opening a can of worms? Gastroenterology 2012; 143: e19.
10. MacConnachie A, Fox R, Kennedy D et al. Faecal transplant for recurrent Clostridium difficile -associated diarrhoea: a UK case series. QJM 2009; 102: 781-4.
11. Rohlke F, Surawicz CM, Stollman N. Fecal flora reconstitution for recurrent Clostridium difficile infection: results and methodology. J Clin Gastroenterol 2010; 44: 567-70.
12. Kelly CR, de Leon L, Jasutkar N. Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results. J Clin Gastroenterol 2012; 46: 145-9.
13. Borody TJ, Warren EF, Leis S et al. Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol 2003; 37: 42-7.
14. Bennet JD, Brinkman M. Treatment of ulcerative colitis by implantation of normal colonic flora. Lancet 1989; 1: 164.
15. Kahn SA, Gorawara-Bhat R, Rubin DT. Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we? Inflamm Bowel Dis 2012; 18: 676-84.
16. Kahn SA, Vachon A, Rodriquez D et al. Patient perceptions of fecal microbiota transplantation for ulcerative colitis. Inflamm Bowel Dis 2013; 19: 1506-13.
17. Singer PA, Siegler M, Lantos JD et al. The ethical assessment of innovative therapies: liver transplantation using living donors. Theor Med 1990; 11: 87-94.
18. Appelbaum PS, Roth LH, Lidz C. The therapeutic misconception: informed consent in psychiatric research. Int J Law Psychiatry 1982; 5: 319-29.
19. Joffe S, Cook EF, Cleary PD et al. Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet 2001; 358: 1772-7.
20. Arras JD. Noncompliance in AIDS research. Hastings Center Report 1990; 20: 24-32.
21. Appelbaum PS, Lidz CW, Grisso T. Therapeutic misconception in clinical research: frequency and risk factors. IRB 2004; 26: 1-8.
22. Glannon W. Phase I Oncology Trials: why the therapeutic misconception will not go away. J Med Ethics 2006; 32: 252-5.